Atsena Therapeutics is a startup based in the United States, most recent round Series-c-plus, 2 tracked investors.
Atsena Therapeutics is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Atsena Therapeutics is a clinical-stage gene therapy company focused on developing treatments to reverse or prevent blindness caused by inherited retinal diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.